CLEC5A and neoplasm: Immunochemistry staining of Ki‐67, a proliferation marker commonly used in pathological assessment, showed that tumour generated by shCLEC5A cells had lower level of Ki‐67 (Figure 6D,E), which further support the hypothesis that knockdown of CLEC5A inhibited tumour cell growth.